SCHEMBL3848976

SCHEMBL3848976

CSc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2ccc3c(c2)ncn3-c2ccc(C(N)=O)cn2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 5/20 0.39
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
DYRK1A Q13627 1/20 0.35
LCK P06239 1/20 0.34
AR P10275 2/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
PRKAB2 O43741 1/20 0.31
ABL1 P00519 1/20 0.31
CSF1R P07333 1/20 0.31
LYN P07948 1/20 0.31
TGFBR1 P36897 1/20 0.31
TGFBR2 P37173 1/20 0.31
PRKAG1 P54619 1/20 0.31
SIK1 P57059 1/20 0.31
PRKAA1 Q13131 1/20 0.31
SIK2 Q9H0K1 1/20 0.31
SIK3 Q9Y2K2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3851788 0.94 DYRK1A (0.39) FGFR1MAPTRAB9ADYRK1ALCK
SCHEMBL3848978 0.86 FGFR1 (0.33) FGFR1MAPTRAB9ADYRK1A
SCHEMBL3849696 0.82 DYRK1A (0.38) FGFR1MAPTRAB9ADYRK1ALCK
SCHEMBL3855970 0.82 DYRK1A (0.38) FGFR1MAPTRAB9ADYRK1ALCK
SCHEMBL3851794 0.80 DYRK1A (0.33) MAPTRAB9ADYRK1A
SCHEMBL3847147 0.77 FGFR1 (0.39) FGFR1MAPTRAB9ADYRK1AALDH1A1
SCHEMBL3845156 0.75 MAPT (0.37) FGFR1MAPTRAB9ADYRK1ALMNA
SCHEMBL3847278 0.74 RAB9A (0.41) MAPTRAB9AALDH1A1LMNAHPGD
SCHEMBL3851232 0.72 ATM (0.41) MAPTRAB9A
SCHEMBL3854592 0.71 FGFR1 (0.35) FGFR1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed